Last reviewed · How we verify

NCT07052526

Comparative Evaluation of Hydrophilic and Hydrophobic Sealants in Partially Erupted First Molars

Not yet recruiting NA Last updated 9 July 2025
What this trial tests

NA trial testing Prevention in Dental Caries in 150 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
1 January 2027
1 April 2027

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment150
Start date1 July 2025
Primary completion1 January 2027
Estimated completion1 April 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 5 to 7, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled clinical trial aims to evaluate and compare the retention, caries prevention, microleakage, and fluoride release of three types of pit and fissure sealants-hydrophilic, nanofilled hydrophobic, and conventional hydrophobic-applied to partially erupted first permanent molars in children aged 5 to 7 years. The study uses a split-mouth design and includes both clinical and laboratory evaluations over an 18-month period. Outcomes will assess sealant effectiveness with and without the use of a bonding agent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Prevention

Trials testing the same drug.

Other recruiting trials for Dental Caries

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07052526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing